» Articles » PMID: 8661718

Production of Congenic Mouse Strains Carrying Genomic Intervals Containing SLE-susceptibility Genes Derived from the SLE-prone NZM2410 Strain

Overview
Journal Mamm Genome
Specialty Genetics
Date 1996 May 1
PMID 8661718
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Systemic lupus erythematosus is inherited as a complex polygenic trait. Four genomic intervals containing major SLE-susceptibility loci were previously identified by interval mapping in the NZM2410 mouse model. In this paper, we utilized a marker-assisted selection protocol to produce four congenic mouse strains, each carrying an NZM2410-derived SLE-susceptibility interval on a C57BL/6-resistant background. Each strain carries only one susceptibility allele derived from this polygenic model and consequently can be used to characterize the specific component phenotypes contributed by individual SLE-susceptibility genes. We illustrate the efficacy of this approach with phenotypic data for one of our congenic strains, B6.NZMH2(z). Our results indicate that this single genomic interval from Chromosome (Chr) 17 of NZM2410 can mediate increased levels of IgG autoantibodies specific for chromatin and that, similar to results obtained in our original genetic cross, B6.NZMH2(z/b) heterozygotes are more prone than B6.NZMH2(z) homozygotes to the development of humoral autoimmunity to nuclear antigens. These results illustrate the feasibility of using congenic strains to dissect the complex pathogenic mechanisms that mediate polygenic SLE. These congenic strains will be valuable tools in the genetic analysis of SLE susceptibility. In future studies, these congenic strains will be interbred to produce bi- and tri-congenic strains in order to assess the role of genetic interactions in the expression of specific components of SLE pathogenesis. They will also be instrumental to the positional cloning and identification of the genes responsible for SLE susceptibility, via the production of congenic recombinants.

Citing Articles

Microbial influences on severity and sex bias of systemic autoimmunity.

Lee J, Reiman D, Singh S, Chang A, Morel L, Chervonsky A Immunol Rev. 2024; 325(1):64-76.

PMID: 38716867 PMC: 11338725. DOI: 10.1111/imr.13341.


Polygenic autoimmune disease risk alleles impacting B cell tolerance act in concert across shared molecular networks in mouse and in humans.

Harley I, Allison K, Scofield R Front Immunol. 2022; 13:953439.

PMID: 36090990 PMC: 9450536. DOI: 10.3389/fimmu.2022.953439.


Mouse Homologue of Human HLA-DO Does Not Preempt Autoimmunity but Controls Murine Gammaherpesvirus MHV68.

Lee J, Cullum E, Stoltz K, Bachmann N, Strong Z, Millick D J Immunol. 2021; 207(12):2944-2951.

PMID: 34810225 PMC: 9124240. DOI: 10.4049/jimmunol.2100650.


Inhibition of B cell activation following co-engagement of B cell antigen receptor and Fcγ receptor IIb in non-autoimmune-prone and SLE-prone mice.

Chu S, Pong E, Bonzon C, Yu N, Jacob C, Chalmers S J Transl Autoimmun. 2021; 4:100075.

PMID: 33409482 PMC: 7773957. DOI: 10.1016/j.jtauto.2020.100075.


Estrogen Receptor Alpha Signaling Is Responsible for the Female Sex Bias in the Loss of Tolerance and Immune Cell Activation Induced by the Lupus Susceptibility Locus .

Graham J, Yoachim S, Gould K Front Immunol. 2020; 11:582214.

PMID: 33240270 PMC: 7683613. DOI: 10.3389/fimmu.2020.582214.


References
1.
Morel L, Rudofsky U, Longmate J, Schiffenbauer J, Wakeland E . Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity. 1994; 1(3):219-29. DOI: 10.1016/1074-7613(94)90100-7. View

2.
Drake C, Rozzo S, Vyse T, Palmer E, Kotzin B . Genetic contributions to lupus-like disease in (NZB x NZW)F1 mice. Immunol Rev. 1995; 144:51-74. DOI: 10.1111/j.1600-065x.1995.tb00065.x. View

3.
Mohan C, Adams S, Stanik V, Datta S . Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993; 177(5):1367-81. PMC: 2191002. DOI: 10.1084/jem.177.5.1367. View

4.
Hylkema M, Huygen H, Kramers C, vd Wal T, de Jong J, van Bruggen M . Clinical evaluation of a modified ELISA, using photobiotinylated DNA, for the detection of anti-DNA antibodies. J Immunol Methods. 1994; 170(1):93-102. DOI: 10.1016/0022-1759(94)90249-6. View

5.
Yui M, Muralidharan K, Perrin G, Chestnut K, Wakeland E . Production of congenic mouse strains carrying NOD-derived diabetogenic genetic intervals: an approach for the genetic dissection of complex traits. Mamm Genome. 1996; 7(5):331-4. DOI: 10.1007/s003359900097. View